ÅǸ޴º
¹øÈ£ | ±¸ºÐ | Á¦¸ñ |
---|---|---|
111 | (±¹¿Ü)SCI | CXCL16 positively correlated with M2-macrophage infiltration, enhanced angiogenesis, and poor prognosis in thyroid cancer |
110 | (±¹³»)KCI | ´ç´¢º´ ȯÀÚÀÇ Æ÷°ýÀû °ü¸® |
109 | (±¹¿Ü)SCIE | Characterization of variable presentations of diabetic ketoacidosis based on blood ketone levels and major society diagnostic criteria: a new view point on the assessment of diabetic ketoacidosis |
108 | (±¹³»)SCIE | 2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea |
107 | (±¹³»)SCIE | Predictors of the Therapeutic Efficacy and Consideration of the Best Combination Therapy of Sodium-Glucose Co-transporter 2 Inhibitors (Diabetes Metab J 2019;43:158-73) |
106 | (±¹¿Ü)SCI | Longitudinal Assessment of Quality of Life According to Treatment Options in Low Risk Papillary Thyroid Microcarcinoma Patients ? Active Surveillance or Immediate Surgery |
105 | (±¹³»)KCI | Sodium-Glucose Cotransporter 2 Inhibitors: Mechanisms of Action and Various Effects |
104 | (±¹¿Ü)SCI | Integrative analysis of genomic and transcriptomic characteristics associated with progression of aggressive thyroid cancer |
103 | (±¹¿Ü)SCI | Restoration of Cellular Proliferation and Characteristics of Human Tenocytes by Vitamin D. |
102 | (±¹¿Ü)SCI | Interaction of BRAF-induced ETS factors with mutant TERT promoter in papillary thyroid cancer |
Copyright ¨Ï chamc, All rights reserved.